GENERAL CE CONFERENCE

SATURDAY, JUNE 21, 2025

Mitigation and Prevention of Medication Errors in Pharmacy Practice

8:00-10:00am G/T (2 hrs.)

Norman P. Tomaka, BS Pharm, MS, CPh, FAPhA, Clinical Consultant Pharmacist, Consultant Pharmacy Services

Upon completion of this activity, pharmacists will be able to: Recognize statutory responsibilities that foster ongoing pharmacy regulatory compliance; Recognize recurring medication errors; Describe quality improvement regulations for pharmacies licensed in Florida; Define elements of a proactive Continuous Quality Improvement process that promotes ongoing quality; Discuss the use of Root Cause Analysis (RCA) to enhance quality pharmacy services and prevent errors; Describe the implementation of an action plan to improve overall pharmacy practice quality and mitigate medication errors; Demonstrate enactment of procedures that promote ongoing patient safety in pharmacy practice.

UAN: 0675-0000-25-021-L05-P

Upon completion of this activity, technicians will be able to: Recognize statutory responsibilities that foster ongoing pharmacy regulatory compliance; Recognize recurring medication errors; Describe quality improvement regulations for pharmacies licensed in Florida; Define elements of a proactive Continuous Quality Improvement process that promotes ongoing quality; Discuss the use of Root Cause Analysis (RCA) to enhance quality pharmacy services and prevent errors; Describe the implementation of an action plan to improve overall pharmacy practice quality and mitigate medication errors; Outline procedures that promote ongoing patient safety in pharmacy practice.

UAN: 0675-0000-25-021-L05-T

HIV AIDS UPDATE

10:15-11:15am G/T (1 hr.)

Elizabeth Sherman, PharmD, Associate Professor of Pharmacy Practice, Principal Investigator, NSU Local Partner Site, South Florida – Southeast AIDS Education and Training Center, Nova Southeastern University

Upon completion of this activity, pharmacists will be able to: Describe epidemiology of HIV/AIDS; Identify modes of HIV transmission & evidenced-based prevention methods to reduce new infections; Define the acronyms PrEP and PEP and describe their applications for pharmacists; Interpret current Florida law on HIV/AIDS and its impact on testing, reporting, confidentiality, procedures for pregnant women and partner notification; Describe current clinical management strategies for HIV/AIDS and related complications; Identify the pharmacist’s role in providing care for people affected by HIV.

UAN: 0675-0000-25-020-L02-P

Upon completion of this activity, technicians will be able to: Identify methods of transmission of HIV/AIDS; List medication agents used to treat HIV/AIDS; Recognize the importance of compliance and the results of opportunistic infections which may occur in patients; Identify ways the technician can provide care for HIV infected patients; Explain current Florida law on HIV/AIDS and its impact on testing, reporting and partner notification.

UAN: 0675-0000-25-020-L02-T

Validation and Counseling of Prescriptions for Controlled Substance and Opioids

11:30-1:30PM G/T (2 hrs.)

Joseph Cammilleri, PharmD, BCACP, CPE, Ambulatory Care Clinical Pharmacist, Pain Management, PGY2 Pain/Palliative Care Program Director, UF Health.

Upon completion of this activity, pharmacists will be able to: Describe how to ensure access to controlled substances for all patients with a valid prescription; Use the Prescription Drug Monitoring Program’s Database; Assess prescriptions for appropriate therapeutic value; Detect prescriptions that are not based on a legitimate medical purpose; Discuss the laws and rules related to the prescribing and dispensing of controlled substances; Discuss proper patient storage and disposal of controlled substances; Discuss protocols for addressing and resolving problems recognized during the drug utilization review; Provide education on section 381.887, F.S., emergency treatment for suspected opioid overdoses and on the State Surgeon General’s Statewide Standing Order for Naloxone; Counsel patients with opioid prescriptions; Provide available treatment resources for opioid physical dependence, addiction, misuse, or abuse. 

UAN: 0675-0000-25-019-L08-P*

Upon completion of this activity, technicians will be able to: Use the Prescription Drug Monitoring Program’s Database; Assess prescriptions for appropriate and accurate information; Recognize the laws and rules related to the prescribing and dispensing of controlled substances. 

UAN: 0675-0000-25-019-L08-T*